APSARD 2026 Symposium
Saturday, January 17, 2026
Location:
Room: Seaport A-C, Second Level
Manchester Grand Hyatt
San Diego, California
Key Details:
- January 17, 2026, 1:15 PM - 2:15 PM (PT)
- Earn up to 1 CME/CE credit
- Complimentary lunch
- Interactive session with live Q&A
- In-Person and Livestreamed
Learning Objectives:
- Describe the neurobehavioral burden of emotional dysregulation and related comorbidities in ADHD (eg, anxiety, executive dysfunction), and examine the limitations of current treatments in addressing these challenging symptom domains
- Explain the role of serotonergic signaling in the regulation of emotion and cognition in ADHD, and describe how serotonin interacts with dopamine and norepinephrine pathways to influence treatment targets
- Evaluate novel pharmacologic targets involving serotonergic modulation as emerging strategies to address under-recognized and under-treated features of ADHD
- Apply individualized, developmentally-informed treatment strategies for patients with stimulant intolerance, comorbid symptoms, or residual impairment in clinical scenarios
Location:
Room: Seaport A-C, Second Level
Manchester Grand Hyatt
San Diego, California
Key Details:
- January 17, 2026, 1:15 PM - 2:15 PM (PT)
- Earn up to 1 CME/CE credit
- Complimentary lunch
- Interactive session with live Q&A
- In-Person and Livestreamed
Learning Objectives:
- Describe the neurobehavioral burden of emotional dysregulation and related comorbidities in ADHD (eg, anxiety, executive dysfunction), and examine the limitations of current treatments in addressing these challenging symptom domains
- Explain the role of serotonergic signaling in the regulation of emotion and cognition in ADHD, and describe how serotonin interacts with dopamine and norepinephrine pathways to influence treatment targets
- Evaluate novel pharmacologic targets involving serotonergic modulation as emerging strategies to address under-recognized and under-treated features of ADHD
- Apply individualized, developmentally-informed treatment strategies for patients with stimulant intolerance, comorbid symptoms, or residual impairment in clinical scenarios
Nationally Recognized Speakers and Premier Education
-
Greg MattinglyDr. Mattingly is a physician and principal investigator in clinical trials...
-
Rakesh JainRakesh Jain, MD, MPH, attended medical school at the University of Calcutta...
-
Craig ChepkeDr. Craig Chepke is a Board-Certified psychiatrist in clinical practice as...
-
Andrew J CutlerDr. Andrew J. Cutler attended Haverford College in Philadelphia...
Who Should Attend?
This educational activity is designed for physicians, advanced-practice nurses, and other clinicians specializing in psychiatry, psychology, neurology, primary care, or pediatrics who care for individuals with ADHD.
All of our symposia are offered at no additional cost to registered attendees of the APSARD Annual Conference.
Registering for the symposium helps us to ensure we have enough space for interested participants and allows us to send you reminders so you don’t forget about the session, but registration is not required.
An on-demand microlearning series with the content presented during the session will be available. We expected it to be posted online 2-4 weeks following the live session.
If you plan to attend the in-person symposium, you must be a registered attendee of APSARD 2026. If you plan to attend virtually, you do not need to be registered for the in-person conference.
Commercial Support
Supported by an educational grant from Otsuka America Pharmaceutical, Inc.
Supported by an educational grant from Otsuka America Pharmaceutical, Inc.